Basic information Safety Supplier Related

2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2

Basic information Safety Supplier Related

2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2 Basic information

Product Name:
2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2
Synonyms:
  • PAR-2 AGONIST II
  • PROTEINASE ACTIVATED RECEPTOR-2 AGONIST II
  • 2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2
  • 2-(2-FUROYL)-LIGRLOAMIDE
  • 2-(2-FUROYL)-PAR-2 (2-6)-ORN AMIDE (MOUSE, RAT)
  • 2F-LIGRLO-AMIDE
  • 2-FUROYL-LEU-ILE-GLY-ARG-LEU-ORN-NH2
  • 2-FUROYL-LIGRLO-AMIDE
CAS:
729589-58-6
MF:
C36H63N11O8
MW:
777.95
Mol File:
729589-58-6.mol
More
Less

2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2 Chemical Properties

Density 
1.33±0.1 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
Soluble in H2O
pka
12.91±0.46(Predicted)
form 
powder
color 
white
Water Solubility 
Soluble to 1 mg/ml in water
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26
WGK Germany 
3
More
Less

2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2 Usage And Synthesis

Uses

2-Furoyl-LIGRLO-amide trifluoroacetate salt may be used as a protease-activated receptor 2 (PAR2) agonist in endothelial progenitor cells (EPCs) and in transient receptor potential cation channel subfamily V member (TRPV4)-transfected HEK293t cells.

General Description

2-Furoyl-LIGRLO-amide trifluoroacetate salt is a peptide that acts as a proteinase-activated receptor-2 (PAR2) agonist, and contains a furoyl group addition at its N-terminal.

Biological Activity

potent and selective par2 receptor agonist (pd2 = 7.0). causes a dose-dependent relaxation of murine femoral arteries.

Biochem/physiol Actions

2-Furoyl-LIGRLO-amide is a potent and selective protease-activated receptor 2 (PAR2) agonist. PAR-2 activation is associated with increases in cAMP and intracellular Ca(2+). Immunoblot analysis revealed increases in phosphorylation of epidermal growth factor (EGF) receptor (EGFR) tyrosine kinase, Src, Pyk2, cRaf, and ERK1/2 in response to PAR-2 activation. 2-Furoyl-LIGRLO-amide is nearly 100-fold more potent than SLIGRL-NH2 (Cat. No. S9317). 2-Furoyl-LIGRLO-amide caused both an endothelium-dependent relaxation and an endothelium-independent contraction. It produced delayed (6 hours later) facilitation of capsaicin-evoked visceral nociception, an effect being much more potent than SLIGRL-NH2. Such effects were mimicked by i.col. trypsin. 2-f-LIGRL-NH2, coadministered repeatedly with caerulein six times in total, abolished the caerulein-evoked abdominal hyperalgesia/allodynia in WT, but not PAR2-KO, mice. Repeated doses of 2-f-LIGRL-NH2 moderately attenuated the severity of caerulein-induced pancreatitis in WT animals. It induced a similar dose-dependent increase in Ca2 levels in the presence and absence of b-arrestins.

storage

Store at -20°C

2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2Supplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Email
ymbetter@glbiochem.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Email
sales@reading-chemicals.com
More
Less

2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2(729589-58-6)Related Product Information